Lakefront Biotherapeutics NV (LKFT) stock
LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 7/30
$34.39−0.40 (-1.15%)
Close on Nov 17, 2026Market cap $2.27BP/E 6.4Yield –
Lakefront Biotherapeutics gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 97.3%, against 87.4% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 97.3% | +10.0 |
| FY2024 | Dec 31, 2024 | 87.4% | −7.6 |
| FY2022 | Dec 31, 2022 | 95.0% | −4.3 |
| FY2021 | Dec 31, 2021 | 99.3% | – |
See a number that looks wrong?